Cargando…
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507223/ https://www.ncbi.nlm.nih.gov/pubmed/37732138 http://dx.doi.org/10.1016/j.lana.2023.100590 |
| _version_ | 1785107267593437184 |
|---|---|
| author | Zeng, Guangting Zhou, Yuchi |
| author_facet | Zeng, Guangting Zhou, Yuchi |
| author_sort | Zeng, Guangting |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10507223 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105072232023-09-20 Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection Zeng, Guangting Zhou, Yuchi Lancet Reg Health Am Correspondence Elsevier 2023-09-08 /pmc/articles/PMC10507223/ /pubmed/37732138 http://dx.doi.org/10.1016/j.lana.2023.100590 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence Zeng, Guangting Zhou, Yuchi Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| title | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| title_full | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| title_fullStr | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| title_full_unstemmed | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| title_short | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| title_sort | pharmacotherapy and pulmonary fibrosis risk after sars-cov-2 infection |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507223/ https://www.ncbi.nlm.nih.gov/pubmed/37732138 http://dx.doi.org/10.1016/j.lana.2023.100590 |
| work_keys_str_mv | AT zengguangting pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infection AT zhouyuchi pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infection |